Citations (138)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alessandro Mannucci, Ferdinando D’Amico, Ahmad El Saadi, Laurent Peyrin-Biroulet & Silvio Danese. (2022) Filgotinib for moderately to severely active ulcerative colitis. Expert Review of Gastroenterology & Hepatology 16:10, pages 927-940.
Read now
Read now
Adrian Egli, Deanna M Santer, Daire O’Shea, D Lorne Tyrrell & Michael Houghton. (2014) The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerging Microbes & Infections 3:1, pages 1-12.
Read now
Read now
Articles from other publishers (136)
S. Solaipriya, N. Mahalakshmi, R. Prajitha & V. Sivaramakrishnan. 2023. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research
353
373
.
Maarja Gruenbach, Christina K. S. Muller, Erika Schlaepfer, Luca Baroncini, Doris Russenberger, Nicole P. Kadzioch, Benjamin Escher, Martin Schlapschy, Arne Skerra, Simon Bredl & Roberto F. Speck. (2022) cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice. Journal of Virology 96:21.
Crossref
Crossref
Steven J. Conrad, Tahseen Raza, Erich A. Peterson, Jason Liem, Richard Connor, Bernice Nounamo, Martin Cannon & Jia Liu. (2022) Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages. PLOS Pathogens 18:9, pages e1010316.
Crossref
Crossref
Kazuki Sakatoku, Yasuhiro Nakashima, Joji Nagasaki, Mitsutaka Nishimoto, Asao Hirose, Mika Nakamae, Hideo Koh, Masayuki Hino & Hirohisa Nakamae. (2022) Immunomodulatory and direct activities of ropeginterferon alfa‐2b on cancer cells in mouse models of leukemia. Cancer Science 113:7, pages 2246-2257.
Crossref
Crossref
Michelle Møhlenberg, Peter Lykke Eriksen, Tea Lund Laursen, Mette Bak Nielsen, Stephen Jacques Hamilton Dutoit, Henning Grønbæk, Rune Hartmann & Karen Louise Thomsen. (2022) The presence of interferon affects the progression of non-alcoholic fatty liver disease. Genes & Immunity 23:5, pages 157-165.
Crossref
Crossref
Ruth Fernandez-Ruiz & Timothy B. Niewold. (2022) Type I Interferons in Autoimmunity. Journal of Investigative Dermatology 142:3, pages 793-803.
Crossref
Crossref
Amy P. Hsu & Steven M. Holland. (2022) Host genetics of innate immune system in infection. Current Opinion in Immunology 74, pages 140-149.
Crossref
Crossref
S. Solaipriya, N. Mahalakshmi, R. Prajitha & V. Sivaramakrishnan. 2022. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research
1
21
.
Christian U. Blank, Deborah J. Wong, Thai H. Ho, Todd M. Bauer, Carrie B. Lee, Fabiola Bene-Tchaleu, Jing Zhu, Xiaosong Zhang, Edward Cha & Mario Sznol. (2021) Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors. Current Oncology 28:6, pages 5466-5479.
Crossref
Crossref
Guanghui Qian, Liyan Zhu, Gen Li, Ying Liu, Zimu Zhang, Jian Pan & Haitao Lv. (2021) An Integrated View of Deubiquitinating Enzymes Involved in Type I Interferon Signaling, Host Defense and Antiviral Activities. Frontiers in Immunology 12.
Crossref
Crossref
Duncan Kirby, Baljyot Parmar, Sepehr Fathi, Sagar Marwah, Chitra R. Nayak, Vera Cherepanov, Sonya MacParland, Jordan J. Feld, Grégoire Altan-Bonnet & Anton Zilman. (2021) Determinants of Ligand Specificity and Functional Plasticity in Type I Interferon Signaling. Frontiers in Immunology 12.
Crossref
Crossref
Christopher James Arthur Duncan & Sophie Hambleton. (2021) Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy. Journal of Clinical Immunology 41:7, pages 1446-1456.
Crossref
Crossref
Masyelly Rojas, Patricia Luz-Crawford, Ricardo Soto-Rifo, Sebastián Reyes-Cerpa & Daniela Toro-Ascuy. (2021) The Landscape of IFN/ISG Signaling in HIV-1-Infected Macrophages and Its Possible Role in the HIV-1 Latency. Cells 10:9, pages 2378.
Crossref
Crossref
Sho Sugawara, Ramy El-Diwany, Laura K. Cohen, Kimberly E. Rousseau, Christopher Y. K. Williams, Rebecca T. Veenhuis, Shruti H. Mehta, Joel N. Blankson, David L. Thomas, Andrea L. Cox & Ashwin Balagopal. (2021) People with HIV-1 Demonstrate Type 1 Interferon Refractoriness Associated with Upregulated USP18. Journal of Virology 95:10.
Crossref
Crossref
Shuai Yan, Manju Kumari, Haopeng Xiao, Christopher Jacobs, Shihab Kochumon, Mark Jedrychowski, Edward Chouchani, Rasheed Ahmad & Evan D. Rosen. (2021) IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis. Journal of Clinical Investigation 131:7.
Crossref
Crossref
Bishara J. Freij, Aidan T. Hanrath, Rui Chen, Sophie Hambleton & Christopher J. A. Duncan. (2021) Life-Threatening Influenza, Hemophagocytic Lymphohistiocytosis and Probable Vaccine-Strain Varicella in a Novel Case of Homozygous STAT2 Deficiency. Frontiers in Immunology 11.
Crossref
Crossref
Adan Pinto-Fernandez, Mariolina Salio, Tom Partridge, Jianzhou Chen, George Vere, Helene Greenwood, Cyriel Sebastiaan Olie, Andreas Damianou, Hannah Claire Scott, Henry Jack Pegg, Alessandra Chiarenza, Laura Díaz-Saez, Paul Smith, Claudia Gonzalez-Lopez, Bhavisha Patel, Emma Anderton, Neil Jones, Tim R. Hammonds, Kilian Huber, Ruth Muschel, Persephone Borrow, Vincenzo Cerundolo & Benedikt M. Kessler. (2020) Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity. British Journal of Cancer 124:4, pages 817-830.
Crossref
Crossref
Megan L. Stanifer, Cuncai Guo, Patricio Doldan & Steeve Boulant. (2020) Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces. Frontiers in Immunology 11.
Crossref
Crossref
Xiao He, Lu Xia, Keyla C. Tumas, Jian Wu & Xin-Zhuan Su. (2020) Type I Interferons and Malaria: A Double-Edge Sword Against a Complex Parasitic Disease. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Alexey A. Lozhkov, Sergey A. Klotchenko, Edward S. Ramsay, Herman D. Moshkoff, Dmitry A. Moshkoff, Andrey V. Vasin & Maria S. Salvato. (2020) The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections. Pathogens 9:12, pages 989.
Crossref
Crossref
Anusorn Mudla, Yanfei Jiang, Kei-ichiro Arimoto, Bingxian Xu, Adarsh Rajesh, Andy P Ryan, Wei Wang, Matthew D Daugherty, Dong-Er Zhang & Nan Hao. (2020) Cell-cycle-gated feedback control mediates desensitization to interferon stimulation. eLife 9.
Crossref
Crossref
Ji An Kang & Young Joo Jeon. (2020) Emerging Roles of USP18: From Biology to Pathophysiology. International Journal of Molecular Sciences 21:18, pages 6825.
Crossref
Crossref
David Holthaus, Andri Vasou, Connor G. G. Bamford, Jelena Andrejeva, Christina Paulus, Richard E. Randall, John McLauchlan & David J. Hughes. (2020) Direct Antiviral Activity of IFN-Stimulated Genes Is Responsible for Resistance to Paramyxoviruses in ISG15-Deficient Cells. The Journal of Immunology 205:1, pages 261-271.
Crossref
Crossref
Frédérique Kok, Marcus Rosenblatt, Melissa Teusel, Tamar Nizharadze, Vladimir Gonçalves Magalhães, Christopher Dächert, Tim Maiwald, Artyom Vlasov, Marvin Wäsch, Silvana Tyufekchieva, Katrin Hoffmann, Georg Damm, Daniel Seehofer, Tobias Boettler, Marco Binder, Jens Timmer, Marcel Schilling & Ursula Klingmüller. (2020) Disentangling molecular mechanisms regulating sensitization of interferon alpha signal transduction. Molecular Systems Biology 16:7.
Crossref
Crossref
Laura Martínez-Aguilar, Cristina Pérez-Ramírez, María del Mar Maldonado-Montoro, María Isabel Carrasco-Campos, Cristina Membrive-Jiménez, Fernando Martínez-Martínez, Carlos García-Collado, Miguel Ángel Calleja-Hernández, María Carmen Ramírez-Tortosa & Alberto Jiménez-Morales. (2020) Effect of genetic polymorphisms on therapeutic response in multiple sclerosis relapsing-remitting patients treated with interferon-beta. Mutation Research/Reviews in Mutation Research 785, pages 108322.
Crossref
Crossref
Christian Urban, Hendrik Welsch, Katharina Heine, Sandra Wüst, Darya A. Haas, Christopher Dächert, Aparna Pandey, Andreas Pichlmair & Marco Binder. (2020) Persistent Innate Immune Stimulation Results in IRF3-Mediated but Caspase-Independent Cytostasis. Viruses 12:6, pages 635.
Crossref
Crossref
Lieselotte Van Bockstal, Dimitri Bulté, Magali Van den Kerkhof, Laura Dirkx, Dorien Mabille, Sarah Hendrickx, Peter Delputte, Louis Maes & Guy Caljon. (2020) Interferon Alpha Favors Macrophage Infection by Visceral Leishmania Species Through Upregulation of Sialoadhesin Expression. Frontiers in Immunology 11.
Crossref
Crossref
Birthe Lohmann, Manuela Silginer, Daniel Picard, Hannah Schneider, Marc Remke, Patrick Roth, Guido Reifenberger & Michael Weller. (2020) Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity. Neuro-Oncology Advances 2:1.
Crossref
Crossref
Christopher J. A. Duncan, Benjamin J. Thompson, Rui ChenGillian I. Rice, Florian Gothe, Dan F. Young, Simon C. LovellVictoria G. ShuttleworthVicky BrocklebankBronte CornerAndrew J. Skelton, Vincent Bondet, Jonathan CoxheadDarragh Duffy, Cecile FourrageJohn H. Livingston, Julija Pavaine, Edmund CheesmanStephania Bitetti, Angela GraingerMeghan AcresBarbara A. InnesAneta MikulasovaRuyue Sun, Rafiqul HussainRonnie Wright, Robert WynnMohammed Zarhrate, Leo A. H. Zeef, Katrina WoodStephen M. Hughes, Claire L. Harris, Karin R. Engelhardt, Yanick J. CrowRichard E. RandallDavid Kavanagh, Sophie Hambleton & Tracy A. Briggs. (2019)
Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in
STAT2
. Science Immunology 4:42.
Crossref
Crossref
Wei-Jia Lu, Fan-Xiang Gao, Yang Wang, Qi-Ya Zhang, Zhi Li, Xiao-Juan Zhang, Li Zhou & Jian-Fang Gui. (2019) Differential expression of innate and adaptive immune genes in the survivors of three gibel carp gynogenetic clones after herpesvirus challenge. BMC Genomics 20:1.
Crossref
Crossref
Marta L. DeDiego, Luis Martinez-Sobrido & David J. Topham. (2019) Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses. Journal of Virology 93:21.
Crossref
Crossref
Michael A. Joyce, Karyn M. Berry-Wynne, Theodore dos Santos, William R. Addison, Nicola McFarlane, Tom Hobman & D. Lorne Tyrrell. (2019) HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response. PLOS Pathogens 15:8, pages e1007949.
Crossref
Crossref
Jan-Hendrik Bockmann, Daniela Stadler, Yuchen Xia, Chunkyu Ko, Jochen M Wettengel, Julian Schulze zur Wiesch, Maura Dandri & Ulrike Protzer. (2019) Comparative Analysis of the Antiviral Effects Mediated by Type I and III Interferons in Hepatitis B Virus–Infected Hepatocytes. The Journal of Infectious Diseases 220:4, pages 567-577.
Crossref
Crossref
Megan L. Stanifer, Kalliopi Pervolaraki & Steeve Boulant. (2019) Differential Regulation of Type I and Type III Interferon Signaling. International Journal of Molecular Sciences 20:6, pages 1445.
Crossref
Crossref
Zongdi Feng & Stanley M. Lemon. (2019) Innate Immunity to Enteric Hepatitis Viruses. Cold Spring Harbor Perspectives in Medicine 9:3, pages a033464.
Crossref
Crossref
Roni Winkler, Ella Gillis, Lior Lasman, Modi Safra, Shay Geula, Clara Soyris, Aharon Nachshon, Julie Tai-Schmiedel, Nehemya Friedman, Vu Thuy Khanh Le-Trilling, Mirko Trilling, Michal Mandelboim, Jacob H. Hanna, Schraga Schwartz & Noam Stern-Ginossar. (2018) m6A modification controls the innate immune response to infection by targeting type I interferons. Nature Immunology 20:2, pages 173-182.
Crossref
Crossref
Barbara Rehermann & Robert Thimme. (2019) Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection. Gastroenterology 156:2, pages 369-383.
Crossref
Crossref
Anja Basters, Klaus-Peter Knobeloch & Günter Fritz. (2018) USP18 – a multifunctional component in the interferon response. Bioscience Reports 38:6.
Crossref
Crossref
Ja-Young Kwon, Paulomi Aldo, Yuan You, Jiahui Ding, Karen Racicot, Xiaoyan Dong, John Murphy, Guy Glukshtad, Michelle Silasi, Jian Peng, Li Wen, Vikki M. Abrahams, Roberto Romero & Gil Mor. (2018) Relevance of placental type I interferon beta regulation for pregnancy success. Cellular & Molecular Immunology 15:12, pages 1010-1026.
Crossref
Crossref
Yun Seob Jung, Dongwoo Chae & Kyungsoo Park. (2018) Population PK-PD Model of Pegylated Interferon Alfa-2a in Healthy Korean Men. Journal of Pharmaceutical Sciences 107:12, pages 3171-3178.
Crossref
Crossref
Kalliopi Pervolaraki, Soheil Rastgou Talemi, Dorothee Albrecht, Felix Bormann, Connor Bamford, Juan L. Mendoza, K. Christopher Garcia, John McLauchlan, Thomas Höfer, Megan L. Stanifer & Steeve Boulant. (2018) Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance. PLOS Pathogens 14:11, pages e1007420.
Crossref
Crossref
Yoshiomi KusakabeKanji UchidaYoshiro YamamuraTakahiro HirumaTokie TotsuYuho TamaiHitoshi TsuyuzakiKyoko HasegawaKyungho ChangYoshitsugu Yamada. (2018) Early-phase Innate Immune Suppression in Murine Severe Sepsis Is Restored with Systemic Interferon-β. Anesthesiology 129:1, pages 131-142.
Crossref
Crossref
Kei-Ichiro Arimoto, Sayuri Miyauchi, Samuel A Stoner, Jun-Bao Fan & Dong-Er Zhang. (2018) Negative regulation of type I IFN signaling. Journal of Leukocyte Biology 103:6, pages 1099-1116.
Crossref
Crossref
Tanja Blumer, Mairene Coto-Llerena, Francois H.T. Duong & Markus H. Heim. (2017) SOCS1 is an inducible negative regulator of interferon λ (IFN-λ)–induced gene expression in vivo. Journal of Biological Chemistry 292:43, pages 17928-17938.
Crossref
Crossref
Jing Cai, Tiande Liu, Xiaoliu Jiang, Changkuo Guo, Anwen Liu & Xinlan Xiao. (2017) Downregulation of USP18 inhibits growth and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma cells by suppressing BCL2L1. Experimental Cell Research 358:2, pages 315-322.
Crossref
Crossref
Nataša Kopitar-Jerala. (2017) The Role of Interferons in Inflammation and Inflammasome Activation. Frontiers in Immunology 8.
Crossref
Crossref
Deanna M. Santer, Gillian E.S. Minty, Adil Mohamed, Lesley Baldwin, Rakesh Bhat, Michael Joyce, Adrian Egli, D. Lorne J. Tyrrell & Michael Houghton. (2017) A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression. Journal of Immunological Methods 445, pages 15-22.
Crossref
Crossref
Kei-ichiro Arimoto, Sara Löchte, Samuel A Stoner, Christoph Burkart, Yue Zhang, Sayuri Miyauchi, Stephan Wilmes, Jun-Bao Fan, Jürgen J Heinisch, Zhi Li, Ming Yan, Sandra Pellegrini, Frédéric Colland, Jacob Piehler & Dong-Er Zhang. (2017) STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling. Nature Structural & Molecular Biology 24:3, pages 279-289.
Crossref
Crossref
Shun Maekawa, Takashi Aoki & Han-Ching Wang. (2017) Constitutive overexpressed type I interferon induced downregulation of antiviral activity in medaka fish ( Oryzias latipes ). Developmental & Comparative Immunology 68, pages 12-20.
Crossref
Crossref
Yusei Miyazaki & Masaaki Niino. (2017) Endogenous type I interferons and their regulators in multiple sclerosis. Clinical and Experimental Neuroimmunology 8, pages 17-23.
Crossref
Crossref
Joshua Ogony, Hye Joung Choi, Asona Lui, Massimo Cristofanilli & Joan Lewis-Wambi. (2016) Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner. Breast Cancer Research 18:1.
Crossref
Crossref
Chuan-Mo Lee, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen & Yi-Hao Yen. (2016) Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients. BMC Gastroenterology 16:1.
Crossref
Crossref
Markus H. Heim, Pierre-Yves Bochud & Jacob George. (2016) Host – hepatitis C viral interactions: The role of genetics. Journal of Hepatology 65:1, pages S22-S32.
Crossref
Crossref
Weiguo Fan, Shiqi Xie, Xinhao Zhao, Nan Li, Chong Chang, Li Li, Ge Yu, Xiumei Chi, Yu Pan, Junqi Niu, Jin Zhong & Bing Sun. (2016) IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18. Journal of General Virology 97:9, pages 2210-2220.
Crossref
Crossref
Antony Adamson, Christopher Boddington, Polly Downton, William Rowe, James Bagnall, Connie Lam, Apolinar Maya-Mendoza, Lorraine Schmidt, Claire V. Harper, David G. Spiller, David A. Rand, Dean A. Jackson, Michael R. H. White & Pawel Paszek. (2016) Signal transduction controls heterogeneous NF-κB dynamics and target gene expression through cytokine-specific refractory states. Nature Communications 7:1.
Crossref
Crossref
Sonya A. MacParland, Xue-Zhong Ma, Limin Chen, Ramzi Khattar, Vera Cherepanov, Markus Selzner, Jordan J. Feld, Nazia Selzner & Ian D. McGilvray. (2016) Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression. Journal of Virology 90:12, pages 5549-5560.
Crossref
Crossref
Lin Li, Qing-song Lei, Shu-Jun Zhang, Ling-na Kong & Bo Qin. (2016) Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling. PLOS ONE 11:5, pages e0156496.
Crossref
Crossref
Tatyana O. Kabilova, Aleksandra V. Sen’kova, Valeriy P. Nikolin, Nelly A. Popova, Marina A. Zenkova, Valentin V. Vlassov & Elena L. Chernolovskaya. (2016) Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice. PLOS ONE 11:3, pages e0150751.
Crossref
Crossref
Ming-Ying Lu, Ching-I Huang, Chia-Yen Dai, Shu-Chi Wang, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Po-Cheng Liang, Yi-Hung Lin, Nai-Jen Hou, Ming-Lun Yeh, Chung-Feng Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Wan-Long Chuang & Ming-Lung Yu. (2016) Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C. Scientific Reports 6:1.
Crossref
Crossref
Héla Saïdi, Marlène Bras, Pauline Formaglio, Marie-Thérèse Melki, Bruno Charbit, Jean-Philippe Herbeuval & Marie-Lise Gougeon. (2016) HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells. PLOS Pathogens 12:2, pages e1005407.
Crossref
Crossref
Elena Carnero & Puri Fortes. (2016) HCV infection, IFN response and the coding and non-coding host cell genome. Virus Research 212, pages 85-102.
Crossref
Crossref
Kui Li. 2016. Hepatitis C Virus I. Hepatitis C Virus I
299
329
.
Volker FensterlSaurabh ChattopadhyayGanes C. Sen. (2015) No Love Lost Between Viruses and Interferons. Annual Review of Virology 2:1, pages 549-572.
Crossref
Crossref
Anannya Bhattacharya, Ahmed N. Hegazy, Nikolaus Deigendesch, Lindsay Kosack, Jovana Cupovic, Richard K. Kandasamy, Andrea Hildebrandt, Doron Merkler, Anja A. Kühl, Bojan Vilagos, Christopher Schliehe, Isabel Panse, Kseniya Khamina, Hatoon Baazim, Isabelle Arnold, Lukas Flatz, Haifeng C. Xu, Philipp A. Lang, Alan Aderem, Akinori Takaoka, Giulio Superti-Furga, Jacques Colinge, Burkhard Ludewig, Max Löhning & Andreas Bergthaler. (2015) Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage. Immunity 43:5, pages 974-986.
Crossref
Crossref
Markus H. Heim. 2015. Signaling Pathways in Liver Diseases. Signaling Pathways in Liver Diseases
214
225
.
Pil Sung, Eui-Cheol Shin & Seung Yoon. (2015) Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection. International Journal of Molecular Sciences 16:10, pages 23683-23694.
Crossref
Crossref
Kine EdvardsenTrine BjånesøyAlexander HellesenLars BreivikMarit BakkeEystein S. HusebyeEirik Bratland. (2015)
Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons
In Vitro
, Despite Elevated Serum Levels of Interferon-Inducible Chemokines
. Journal of Interferon & Cytokine Research 35:10, pages 759-770.
Crossref
Crossref
Chen Chen, Yi-Bing Zhang & Jian-Fang Gui. (2015) Expression characterization, genomic structure and function analysis of fish ubiquitin-specific protease 18 (USP18) genes. Developmental & Comparative Immunology 52:2, pages 112-122.
Crossref
Crossref
Scott A. Read, Enoch S. Tay, Mahsa Shahidi, Kate S. O’Connor, David R. Booth, Jacob George & Mark W. Douglas. (2015) Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response. PLOS ONE 10:8, pages e0136227.
Crossref
Crossref
Pil Soo SungHyeonJoo CheonChung Hwan ChoSeon-Hui HongDo Youn ParkHyung-Il SeoSu-Hyung ParkSeung Kew Yoon, George R. StarkEui-Cheol Shin. (2015) Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness. Proceedings of the National Academy of Sciences 112:33, pages 10443-10448.
Crossref
Crossref
Joshua S. TaylorQingling ZhangJustin G. JulanderAntitsa D. StoychevaHua TanChristabel V. MoySushmita ChandaJulian A. SymonsLeonid N. BeigelmanLawrence M. BlattJin Hong. (2015) Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies. Journal of Interferon & Cytokine Research 35:8, pages 621-633.
Crossref
Crossref
M Noureddin, Y Rotman, F Zhang, H Park, B Rehermann, E Thomas & T J Liang. (2015) Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype–genotype correlation study. Genes & Immunity 16:5, pages 321-329.
Crossref
Crossref
Jamshed Warsi, Zohreh Hosseinzadeh, Bernat Elvira, Lisann Pelzl, Ekaterina Shumilina, Dong-Er Zhang, Karl S. Lang, Philipp A. Lang & Florian Lang. (2015) USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2. PLOS ONE 10:6, pages e0129365.
Crossref
Crossref
P.-S. Sultanik, A. Casrouge, C. Alanio, E. Mottez, I. Rosa-Hézode, C. Hézode, P. Renard, L. Bousquet, P. Pellet, G. Uzé, S. Pol, M. L. Albert & V. Mallet. (2015) Baseline sensitivity of T cells to alpha-IFN correlates with sustained virological response to IFN-based triple therapy in HCV infection. Journal of Viral Hepatitis 22:6, pages 524-534.
Crossref
Crossref
D. Harari, I. Orr, R. Rotkopf, S. E. Baranzini & G. Schreiber. (2015) A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFN drugs in the treatment of multiple sclerosis. Human Molecular Genetics 24:11, pages 3192-3205.
Crossref
Crossref
Scott A. ReadEnoch S. TayMahsa ShahidiJohn McLauchlanJacob GeorgeMark W. Douglas. (2015) The Mechanism of Interferon Refractoriness During Hepatitis C Virus Infection and Its Reversal with a Peroxisome Proliferator-Activated Receptor α Agonist. Journal of Interferon & Cytokine Research 35:6, pages 488-497.
Crossref
Crossref
Guido Antonelli, Carolina Scagnolari, Federica Moschella & Enrico Proietti. (2015) Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use. Cytokine & Growth Factor Reviews 26:2, pages 121-131.
Crossref
Crossref
Jacques Friborg, Petra Ross-Macdonald, Jian Cao, Ryan Willard, Baiqing Lin, Betsy Eggers & Fiona McPhee. (2015) Impairment of Type I but Not Type III IFN Signaling by Hepatitis C Virus Infection Influences Antiviral Responses in Primary Human Hepatocytes. PLOS ONE 10:3, pages e0121734.
Crossref
Crossref
Lars KetscherRonny HannßDavid J. MoralesAnja BastersSusana GuerraTobias GoldmannAnnika HausmannMarco PrinzRonald NaumannAndrew PekoszOlaf Utermöhlen, Deborah J. LenschowKlaus-Peter Knobeloch. (2015) Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance. Proceedings of the National Academy of Sciences 112:5, pages 1577-1582.
Crossref
Crossref
Barbara Rehermann & Antonio Bertoletti. (2015) Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections. Hepatology 61:2, pages 712-721.
Crossref
Crossref
Marina Barriocanal, Elena Carnero, Victor Segura & Puri Fortes. (2015) Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin. Frontiers in Immunology 5.
Crossref
Crossref
Jiaren Sun. (2015) Immune and non-immune responses to hepatitis C virus infection. World Journal of Gastroenterology 21:38, pages 10739.
Crossref
Crossref
Bing Liu, Ian McGilvray & Limin Chen. (2015)
IFN-
λ
: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research
. Gastroenterology Research and Practice 2015, pages 1-9.
Crossref
Crossref
Ewa Terczyńska-Dyla, Stephanie Bibert, Francois H. T. Duong, Ilona Krol, Sanne Jørgensen, Emilie Collinet, Zoltán Kutalik, Vincent Aubert, Andreas Cerny, Laurent Kaiser, Raffaele Malinverni, Alessandra Mangia, Darius Moradpour, Beat Müllhaupt, Francesco Negro, Rosanna Santoro, David Semela, Nasser Semmo, Laura Rubbia-Brandt, Gladys Martinetti, Meri Gorgievski, Jean-François Dufour, Hans Hirsch, Beat Helbling, Stephan Regenass, Guenter Dollenmaier, Gieri Cathomas, Markus H. Heim, Pierre-Yves Bochud & Rune Hartmann. (2014) Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nature Communications 5:1.
Crossref
Crossref
Nandan S Gokhale, Christine Vazquez & Stacy M Horner. (2014) Hepatitis C virus: strategies to evade antiviral responses. Future Virology 9:12, pages 1061-1075.
Crossref
Crossref
Elena Carnero, Marina Barriocanal, Victor Segura, Elizabeth Guruceaga, Celia Prior, Kathleen Börner, Dirk Grimm & Puri Fortes. (2014) Type I Interferon Regulates the Expression of Long Non-Coding RNAs. Frontiers in Immunology 5.
Crossref
Crossref
Erik S. Barton, Sujana Rajkarnikar, P. Kent Langston, Madeline J. Price & Jason M. Grayson. (2014)
Gammaherpesvirus Latency Differentially Impacts the Generation of Primary versus Secondary Memory CD8
+
T Cells during Subsequent Infection
. Journal of Virology 88:21, pages 12740-12751.
Crossref
Crossref
Markus H. Heim & Robert Thimme. (2014) Innate and adaptive immune responses in HCV infections. Journal of Hepatology 61:1, pages S14-S25.
Crossref
Crossref
Stephen M. Laidlaw & Lynn B. Dustin. (2014) Interferon Lambda: Opportunities, Risks, and Uncertainties in the Fight Against HCV. Frontiers in Immunology 5.
Crossref
Crossref
BARBARA SZOMOLAY & EDWARD M. LUNGU. (2014) A MATHEMATICAL MODEL FOR THE TREATMENT OF AIDS-RELATED KAPOSI'S SARCOMA. Journal of Biological Systems 22:03, pages 495-522.
Crossref
Crossref
Yujia Li, Shilin Li, Xiaoqiong Duan, Bing Liu, Chunhui Yang, Peibin Zeng, Ian McGilvray & Limin Chen. (2014) Activation of endogenous type I IFN signaling contributes to persistent HCV infection. Reviews in Medical Virology 24:5, pages 332-342.
Crossref
Crossref
Christian M. Lange, Jérôme Gouttenoire, François H. T. Duong, Kenichi Morikawa, Markus H. Heim & Darius Moradpour. (2014) Vitamin D Receptor and Jak–STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN-α. The Journal of Immunology 192:12, pages 6037-6044.
Crossref
Crossref
Francois H.T. Duong, Gaia Trincucci, Tujana Boldanova, Diego Calabrese, Benedetta Campana, Ilona Krol, Sarah C. Durand, Laura Heydmann, Mirjam B. Zeisel, Thomas F. Baumert & Markus H. Heim. (2014) IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies. Journal of Experimental Medicine 211:5, pages 857-868.
Crossref
Crossref
Michael T. Dill, Zuzanna Makowska, Gaia Trincucci, Andreas J. Gruber, Julia E. Vogt, Magdalena Filipowicz, Diego Calabrese, Ilona Krol, Daryl T. Lau, Luigi Terracciano, Erik van Nimwegen, Volker Roth & Markus H. Heim. (2014) Pegylated IFN-α regulates hepatic gene expression through transient Jak/STAT activation. Journal of Clinical Investigation 124:4, pages 1568-1581.
Crossref
Crossref
Ivan Rusyn & Stanley M. Lemon. (2014) Mechanisms of HCV-induced liver cancer: What did we learn from in vitro and animal studies?. Cancer Letters 345:2, pages 210-215.
Crossref
Crossref
Stacy M. Horner. (2014) Activation and Evasion of Antiviral Innate Immunity by Hepatitis C Virus. Journal of Molecular Biology 426:6, pages 1198-1209.
Crossref
Crossref
Lena Allweiss, Tassilo Volz, Marc Lütgehetmann, Katja Giersch, Till Bornscheuer, Ansgar W. Lohse, Joerg Petersen, Han Ma, Klaus Klumpp, Simon P. Fletcher & Maura Dandri. (2014) Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration. Journal of Hepatology 60:3, pages 500-507.
Crossref
Crossref
Feyza Gunduz, Chaithanya Mallikarjun, Luis A. Balart & Srikanta Dash. (2014) Interferon alpha induced intrahepatic pSTAT1 inversely correlate with serum HCV RNA levels in chronic HCV infection. Experimental and Molecular Pathology 96:1, pages 36-41.
Crossref
Crossref
Pascale Hermant, Céline Demarez, Tanel Mahlakõiv, Peter Staeheli, Philip Meuleman & Thomas Michiels. (2014) Human but Not Mouse Hepatocytes Respond to Interferon-Lambda In Vivo. PLoS ONE 9:1, pages e87906.
Crossref
Crossref
Pascale Hermant & Thomas Michiels. (2014) Interferon-λ in the Context of Viral Infections: Production, Response and Therapeutic Implications. Journal of Innate Immunity 6:5, pages 563-574.
Crossref
Crossref
Yaron Rotman, Mazen Noureddin, Jordan J Feld, Jeremie Guedj, Michael Witthaus, Hwalih Han, Yoon J Park, Su-Hyung Park, Theo Heller, Marc G Ghany, Edward Doo, Christopher Koh, Adil Abdalla, Naveen Gara, Souvik Sarkar, Emmanuel Thomas, Golo Ahlenstiel, Birgit Edlich, Rachel Titerence, Leah Hogdal, Barbara Rehermann, Harel Dahari, Alan S Perelson, Jay H Hoofnagle & T Jake Liang. (2014) Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut 63:1, pages 161-169.
Crossref
Crossref
François H.T. Duong, Michael T. Dill, Matthias S. Matter, Zuzanna Makowska, Diego Calabrese, Tanja Dietsche, Sylvia Ketterer, Luigi Terracciano & Markus H. Heim. (2014) Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53. Carcinogenesis 35:1, pages 114-122.
Crossref
Crossref
Lionel B. Ivashkiv & Laura T. Donlin. (2013) Regulation of type I interferon responses. Nature Reviews Immunology 14:1, pages 36-49.
Crossref
Crossref
Zobair Younossi, Francesco Negro, Lawrence Serfaty, Stanislas Pol, Moises Diago, Stefan Zeuzem, Pietro Andreone, Eric J. Lawitz, Stuart Roberts, Roberto Focaccia, Graham R. Foster, Andrzej Horban, Isabelle Lonjon-Domanec, Bruce Coate, Ralph DeMasi, Gaston Picchio & James Witek. (2013) Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial. Hepatology 58:6, pages 1897-1906.
Crossref
Crossref
Jordan J. Feld, Jason Grebely, Gail V. Matthews, Tanya Applegate, Margaret Hellard, Alana Sherker, Vera Cherepanov, Kathy Petoumenos, Barbara Yeung, John M. Kaldor, Andrew R. Lloyd & Gregory J. Dore. (2013) Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection. PLoS ONE 8:11, pages e80003.
Crossref
Crossref
Janett Fischer, Stephan Böhm, Tobias Müller, Heiko Witt, Christoph Sarrazin, Simone Susser, Pascal Migaud, Eckart Schott, Graeme Stewart, Annika Brodzinski, Balazs Fülöp, Florian van Bömmel, Jacob George & Thomas Berg. (2013) Association of IFNL3 rs12979860 and rs8099917 with Biochemical Predictors of Interferon Responsiveness in Chronic Hepatitis C Virus Infection. PLoS ONE 8:10, pages e77530.
Crossref
Crossref
Hugo R. Rosen. (2013) Emerging concepts in immunity to hepatitis C virus infection. Journal of Clinical Investigation 123:10, pages 4121-4130.
Crossref
Crossref
S. Malhotra, C. Morcillo-Suárez, R. Nurtdinov, J. Rio, E. Sarro, M. Moreno, J. Castilló, A. Navarro, X. Montalban & M. Comabella. (2013)
Roles of the ubiquitin peptidase
USP18
in multiple sclerosis and the response to interferon-
β
treatment
. European Journal of Neurology 20:10, pages 1390-1397.
Crossref
Crossref
Jacques Friborg, Baiqing Lin, Chaoqun Chen & Fiona McPhee. (2013) Isolation and characterization of interferon lambda-resistant hepatitis C virus replicon cell lines. Virology 444:1-2, pages 384-393.
Crossref
Crossref
Markus H. Heim. (2013) 25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end. Nature Reviews Immunology 13:7, pages 535-542.
Crossref
Crossref
Joachim Lupberger, Daniel J. Felmlee & Thomas F. Baumert. (2013) Interferon-lambda polymorphisms and hepatitis C virus clearance revisited. Hepatology 58:1, pages 439-441.
Crossref
Crossref
Zuzanna Makowska, Tanja Blumer, François H.T. Duong, Nicola La Monica, Ekambar R. Kandimalla & Markus H. Heim. (2013) Sequential induction of type I and II interferons mediates a long-lasting gene induction in the liver in response to a novel toll-like receptor 9 agonist. Journal of Hepatology 58:4, pages 743-749.
Crossref
Crossref
Markus H. Heim. (2013) Innate immunity and HCV. Journal of Hepatology 58:3, pages 564-574.
Crossref
Crossref
Kui Li & Stanley M. Lemon. (2012) Innate immune responses in hepatitis C virus infection. Seminars in Immunopathology 35:1, pages 53-72.
Crossref
Crossref
John W. Schoggins & Charles M. Rice. 2013. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy. Hepatitis C Virus: From Molecular Virology to Antiviral Therapy
219
242
.
Andrea Sgorbissa & Claudio Brancolini. (2012) IFNs, ISGylation and cancer: Cui prodest?. Cytokine & Growth Factor Reviews 23:6, pages 307-314.
Crossref
Crossref
I Santin, F Moore, F A Grieco, P Marchetti, C Brancolini & D L Eizirik. (2012) USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis. Cell Death & Disease 3:11, pages e419-e419.
Crossref
Crossref
Stéphanie Dabo & Eliane Meurs. (2012) dsRNA-Dependent Protein Kinase PKR and its Role in Stress, Signaling and HCV Infection. Viruses 4:11, pages 2598-2635.
Crossref
Crossref
Michael T. Dill, Zuzanna Makowska, Francois H.T. Duong, Franzisca Merkofer, Magdalena Filipowicz, Thomas F. Baumert, Luigi Tornillo, Luigi Terracciano & Markus H. Heim. (2012) Interferon-γ–Stimulated Genes, but Not USP18, Are Expressed in Livers of Patients With Acute Hepatitis C. Gastroenterology 143:3, pages 777-786.e6.
Crossref
Crossref
Zuzanna Makowska & Markus H. Heim. (2012) Interferon signaling in the liver during hepatitis C virus infection. Cytokine 59:3, pages 460-466.
Crossref
Crossref
Xiu-Li Cong, Miao-Chia Lo, Brian A. Reuter, Ming Yan, Jun-Bao Fan & Dong-Er Zhang. (2012) Usp18 Promotes Conventional CD11b+ Dendritic Cell Development. The Journal of Immunology 188:10, pages 4776-4781.
Crossref
Crossref
Giulia Marchetti, Paola Nasta, Francesca Bai, Francesca Gatti, Giusi Maria Bellistrì, Camilla Tincati, Federica Borghi, Giampiero Carosi, Massimo Puoti & Antonella d'Arminio Monforte. (2012) Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients. PLoS ONE 7:2, pages e32028.
Crossref
Crossref
Christoph Burkart, Jun-Bao Fan & Dong-Er Zhang. (2012) Two Independent Mechanisms Promote Expression of an N-terminal Truncated USP18 Isoform with Higher DeISGylation Activity in the Nucleus. Journal of Biological Chemistry 287:7, pages 4883-4893.
Crossref
Crossref
E. J. Murray, Frances Burden, Nigel Horscroft, Caroline Smith-Burchnell & Mike Westby. (2011) Knockdown of USP18 Increases Alpha 2a Interferon Signaling and Induction of Interferon-Stimulating Genes but Does Not Increase Antiviral Activity in Huh7 Cells. Antimicrobial Agents and Chemotherapy 55:9, pages 4311-4319.
Crossref
Crossref
Johan Tisserand, Konstantin Khetchoumian, Christelle Thibault, Doulaye Dembélé, Pierre Chambon & Régine Losson. (2011) Tripartite Motif 24 (Trim24/Tif1α) Tumor Suppressor Protein Is a Novel Negative Regulator of Interferon (IFN)/Signal Transducers and Activators of Transcription (STAT) Signaling Pathway Acting through Retinoic Acid Receptor α (Rarα) Inhibition. Journal of Biological Chemistry 286:38, pages 33369-33379.
Crossref
Crossref
Véronique François-Newton, Gabriel Magno de Freitas Almeida, Béatrice Payelle-Brogard, Danièle Monneron, Lydiane Pichard-Garcia, Jacob Piehler, Sandra Pellegrini & Gilles Uzé. (2011) USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response. PLoS ONE 6:7, pages e22200.
Crossref
Crossref
Barbara Testoni, Christine Völlenkle, Francesca Guerrieri, Sabine Gerbal-Chaloin, Giovanni Blandino & Massimo Levrero. (2011) Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2. Journal of Biological Chemistry 286:23, pages 20217-20227.
Crossref
Crossref
Julia Schmidt, Robert Thimme & Christoph Neumann-Haefelin. (2011) Host genetics in immune-mediated hepatitis C virus clearance. Biomarkers in Medicine 5:2, pages 155-169.
Crossref
Crossref
Zuzanna Makowska, Francois H. T. Duong, Gaia Trincucci, David F. Tough & Markus H. Heim. (2011) Interferon-β and interferon-λ signaling is not affected by interferon-induced refractoriness to interferon-α in vivo. Hepatology 53:4, pages 1171-1180.
Crossref
Crossref
Michael T. Dill, Francois H.T. Duong, Julia E. Vogt, Stéphanie Bibert, Pierre–Yves Bochud, Luigi Terracciano, Andreas Papassotiropoulos, Volker Roth & Markus H. Heim. (2011) Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Response Than IL28B Genotype in Patients With Hepatitis C. Gastroenterology 140:3, pages 1021-1031.e10.
Crossref
Crossref
Jing Cai, Xiang-Li Zhao, An-Wen Liu, Hua Nian & Shu-Hui Zhang. (2011) Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns. Phytomedicine 18:5, pages 366-373.
Crossref
Crossref
Tim Maiwald, Annette Schneider, Hauke Busch, Sven Sahle, Norbert Gretz, Thomas S. Weiss, Ursula Kummer & Ursula Klingmüller. (2010) Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling. FEBS Journal 277:22, pages 4741-4754.
Crossref
Crossref
Spyridon Stavrou, Zongdi Feng, Stanley M. Lemon & Raymond P. Roos. (2010) Different Strains of Theiler's Murine Encephalomyelitis Virus Antagonize Different Sites in the Type I Interferon Pathway. Journal of Virology 84:18, pages 9181-9189.
Crossref
Crossref
Stanley M. Lemon. (2010) Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus. Journal of Biological Chemistry 285:30, pages 22741-22747.
Crossref
Crossref
Aaron Farnsworth, Anathea S. Flaman, Shiv S. Prasad, Caroline Gravel, Andrew Williams, Carole L. Yauk & Xuguang Li. (2010) Acetaminophen Modulates the Transcriptional Response to Recombinant Interferon-β. PLoS ONE 5:6, pages e11031.
Crossref
Crossref
Markus Heim. (2009) HCV Innate Immune Responses. Viruses 1:3, pages 1073-1088.
Crossref
Crossref